黄芽疏肝汤治疗慢性浅表性胃炎30例  

Thirty Cases with Chronic Superficial Gastritis Treated with Huangya Shugan Decoction

作　　者：罗文[1] 胡则林[1] 黎祥胜[2] 

机构地区：[1]华中科技大学医院,湖北武汉430074 [2]湖北省中医院,湖北武汉430000

出　　处：《河南中医》2017年第11期1978-1980,共3页Henan Traditional Chinese Medicine

基　　金：湖北省卫生科研基金项目(编号:JX5B70)

摘　　要：目的:观察黄芽疏肝汤治疗慢性浅表性胃炎的临床疗效。方法:选取本院2015年1月—2016年2月收治的60例慢性浅表性胃炎患者为研究对象,随机分为对照组和治疗组,每组各30例。对照组采用奥美拉唑肠溶胶囊治疗,治疗组采用黄芽疏肝汤治疗。观察两组患者的临床疗效,比较两组患者治疗前后中医证候积分和治疗后健康状况积分变化情况。结果:对照组有效率为63.3%,治疗组有效率为86.7%,两组患者临床疗效比较,差异有统计学意义(P<0.05)。两组患者治疗后中医证候积分低于治疗前,且治疗组低于对照组,差异有统计学意义(P<0.05)。对照组饮食、情绪、精力、睡眠、疼痛、排便、体质等积分高于治疗组,差异有统计学意义(P<0.05)。结论:黄芽疏肝汤治疗慢性浅表性胃炎疗效显著,能有效缓解临床症状与体征,改善机体健康水平。Objective： To observe the clinical effects of Huangya Shugan Decoction on chronic superficial gastritis（ CSG）. Method： Totally 60 patients with CSG treated between January 2015 and February 2016 were randomized into control group and treatment group,30 cases in each group. Control group were given Omeprazole Enteric Capsules while treatment group were given Huangya Shugan Decoction. The clinical effects of both groups were observed. The TCM symptom scores and health scores between the two groups were compared. Results： The effective rate was 63. 3% in control group and 86. 7% in treatment group; the difference had statistical significance（ P〈0. 05）. The TCM symptom scores in both groups declined,and the decline in treatment group was greater than that in control group,with statistical difference（ P〈0. 05）. The scores of diet,mood,vitality,sleep,pain,defecation and urination and constitution in control group in control group were higher than those in treatment group,with statistical difference（ P〈0. 05）. Conclusion： Huangya Shugan Decoction has significant therapeutic effects on CSG,which can effectively improve the clinical symptoms and signs and the individual health condition.

关 键 词：慢性浅表性胃炎 黄芽疏肝汤 奥美拉唑肠溶胶囊 

分 类 号：R259.733.1[医药卫生—中西医结合]